Skip to main content

Table 6 Ten years survival in patients with Hurthle cell carcinoma

From: Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience

  Period of study Number of patients Overall survival (%) Cancer specific survival (%) Disease free interval (%)
Haigh et al. (SEER) [16] 1988–1993 172 73   
Lopez-Penabad et al. [14] 1944–1995 89 55 64  
Bhattacharyya et al. (SEER) [4] 1973–1998 555 71.1   
Stojadinovic et al. [7] 1940–2000 56   73 61
Kushchayeva et al. [11] 1976–2002 33   49 40.5
Mills et al. [8] 1946–2003 62   64 43
Jillard et al. (National Cancer Database) [17] 1998–2006 1909 70.7   
Nagar et al. (SEER-9) [1] 1975–2009 1416 77.1   
Goffredo et al. (SEER) [2] 1988–2009 3311   91  
Sugino et al. [10] 1989–2010 73   93.1  
Petric et al. [6] 1972–2011 108   88 68
Our study 1995–2014 239 77.2 92.5 86.2
  1. SEER surveillance, epidemiology, and end results